6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
3h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
4h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
6h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
13h ago	Buffalo Potash Files Annual Information Form and New Technical Report
14h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

3.03USD+0.09 +3.03%

Closed • Updated at 17:24 GMT+00:00

Market Cap$6.94M

Volume19.9K

Beta-0.56

RSI49.94

Health TechnologyPharmaceuticals: Major

Xenetic Biosciences, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform

Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting

Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform

Community Chat

Ask AI